KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares Outstanding
Ratios

Astrana Health (ASTH) Non-Current Receivables (2016 - 2025)

Historic Non-Current Receivables for Astrana Health (ASTH) over the last 10 years, with Q3 2025 value amounting to $48.5 million.

  • Astrana Health's Non-Current Receivables rose 20404.57% to $48.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.5 million, marking a year-over-year increase of 20404.57%. This contributed to the annual value of $51.3 million for FY2024, which is 9365.39% up from last year.
  • As of Q3 2025, Astrana Health's Non-Current Receivables stood at $48.5 million, which was up 20404.57% from $48.4 million recorded in Q2 2025.
  • In the past 5 years, Astrana Health's Non-Current Receivables ranged from a high of $51.3 million in Q4 2024 and a low of $6.5 million during Q1 2021
  • In the last 5 years, Astrana Health's Non-Current Receivables had a median value of $15.9 million in 2021 and averaged $22.5 million.
  • As far as peak fluctuations go, Astrana Health's Non-Current Receivables soared by 28463.21% in 2021, and later crashed by 3632.99% in 2024.
  • Over the past 5 years, Astrana Health's Non-Current Receivables (Quarter) stood at $15.9 million in 2021, then changed by 0.0% to $15.9 million in 2022, then surged by 66.05% to $26.5 million in 2023, then skyrocketed by 93.65% to $51.3 million in 2024, then decreased by 5.45% to $48.5 million in 2025.
  • Its Non-Current Receivables was $48.5 million in Q3 2025, compared to $48.4 million in Q2 2025 and $48.1 million in Q1 2025.